12 September, 2012
In the past two years, Quality by Design has been frequently discussed, mainly in connection to implementation of FDA’s QbD guidance in pharmaceutical production. What has been improved and achieved during this period? Are you interested in concrete facts and do you want to explore the best practices that work?
8TH ANNUAL QUALITY and OPERATIONAL EXCELLENCE IN PHARMA MANUFACTURING
4 – 5 October 2012, Le Meridien Parkhotel, Frankfurt
Best practices to embrace lean thinking in manufacturing and establish a global network that is aligned around the same goals
RENEE DINEEN, Head of Organization Development Small Molecules, Global Technical Operations, Roche, Switzerland
SVEN HAUPTMANN, Managing Director, Roche, Ireland
Corrective and preventive action (CAPA): An aseptic manufacturing case study
TUNDE GAL, GMP Auditor, Head of the Audit Team, Teva Pharmaceutical, Hungary
To see all the topics to be presented at our conference, feel free to request the agenda at http://pharma.flemingeurope.com/quality/request-agenda/
Additionally, you will get special insight into the compliance, control, flexibility and efficiency of quality management! Read the case study by FormPipe Life Sciences here http://pharma.flemingeurope.com/quality/formpipe-life-science
Tel: +421 257 272 335
Fax: +421 255 644 490
About Fleming Europe
Established in Slovakia, Fleming Europe represents a Pan-European B2B networking channel for specialists to collect and share knowledge. Since 2004, the company has been encouraging decision makers to share their experiences through market leading conferences, trainings and webinars. The annual audience of 10,000 Banking, Defense, Energy, Oil and Gas, Pharma, Telco and Transport peers benefit from insights on industry trends when applying them to their own business practices.
For more information visit www.flemingeurope.com